Provided by Tiger Trade Technology Pte. Ltd.

FOSUN PHARMA

17.140
+0.2101.24%
Volume:2.79M
Turnover:47.74M
Market Cap:45.47B
PE:11.54
High:17.260
Open:16.780
Low:16.780
Close:16.930
52wk High:28.232
52wk Low:14.505
Shares:2.65B
HK Float Shares:535.00M
Volume Ratio:0.49
T/O Rate:0.52%
Dividend:0.45
Dividend Rate:2.63%
EPS(LYR):1.486
ROE:6.95%
ROA:1.40%
PB:0.80
PE(LYR):11.54
PS:0.91

Loading ...

Fosun Pharma Unit Passes GMP Inspection

MT Newswires Live
·
Jun 18

Fosun Pharma Gets China Nod to Trial HLX3902 Injection

MT Newswires Live
·
Jun 18

Fosun Pharma Subsidiary Passes GMP Compliance Inspection

Stock News
·
Jun 17

Fosun Pharma Announces Final Dividend of RMB 0.39 Per Share for Payment on August 14

Stock News
·
Jun 16

Fosun Pharma Secures Shareholder Support for All AGM Proposals; Announces RMB0.39 Final Dividend

Bulletin Express
·
Jun 16

Fosun Pharma Unit's Luvometinib Gets China Nod for Langerhans Cell Histiocytosis Drug Indication

MT Newswires Live
·
Jun 16

Fosun Pharma Showcases Strategy at Abu Dhabi Forum, Highlighting Innovation and Collaboration as Key to China-UAE Healthcare Partnership

Deep News
·
Jun 15

Fosun Pharma secures NMPA nod for Luvometinib’s pediatric LCH indication, lifting rare-tumor portfolio

Bulletin Express
·
Jun 15

Shanghai Fosun Pharma - Drug Registration Application for Additional Indication of Luvometinib Tablets Approved by Nmpa

THOMSON REUTERS
·
Jun 15

Fosun Pharma's Shareholder Meeting Hints at Major Moves: Billions in Guarantees and Dual A/H Share Buybacks Revealed

Deep News
·
Jun 13

Sinopharm Group Stock Falls 1.6% in Hong Kong

Dow Jones
·
Jun 11

FOSUN INTL's "Strongest Valuation Anchor" Solidifies as Innovative Drug R&D and Commercialization Accelerates

Stock News
·
Jun 03

Subsidiary of FOSUN PHARMA Gains Approval for Pertuzumab Injection

Stock News
·
May 29

FOSUN PHARMA Invests Over 400 Million Yuan in Nucleic Acid Drug Firm

Deep News
·
May 27

Sinopharm Group Stock Falls 1.7% in Hong Kong

Dow Jones
·
May 27

Fosun Pharmaceutical to Invest 414 Million Yuan in Xingyao Kunze's Series B Funding Round

MT Newswires Live
·
May 27

Fosun Pharma Gets Registration Nod for Infection Drug in China

MT Newswires Live
·
May 21

Fosun Pharma receives NMPA clearance for Yaopharma-developed Levofloxacin Injection

Bulletin Express
·
May 21

FOSUN PHARMA Subsidiary Gains Approval for Levofloxacin Injection

Stock News
·
May 21

Shanghai Fosun Pharma - Drug Registration Application for Levofloxacin Injection Approved by China's Nmpa

THOMSON REUTERS
·
May 21